Ryali Sriram bought CRBU
February 20, 2026 · Form 4 insider transaction
Ryali Sriram bought 55,000 shares of Caribou Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
55,000
Price
$0.00
Total value
N/A
InsiderRyali Sriram
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 20, 2026
Filing dateFebruary 20, 2026
Shares owned after72,360
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This reflects restricted stock units ("RSUs") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date.